Erin Gainer is a global leader and strategist in women’s health pharmaceuticals. She is Chair of the Board of HRA Pharma and was CEO for 16 years, where she led the development and launch of an extensive portfolio of innovative women’s health products, including the company’s flagship emergency contraceptive products ellaOne® and NorLevo®. A graduate from Rice University and John Hopkins School of Public Health, Erin Gainer has a PHD from Paris-Sud University and an EMBA from INSEAD. She is the founder of the Ella Fund, which empowers girls and women globally by funding innovative healthcare, education and entrepreneurship initiatives worldwide.